,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,477031,5281616,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,477031,5281616,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,477031,5281616,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,477031,5281616,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,477031,5281616,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,477031,5281616,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,410,1,5,,11113137,5281616,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
7,411,2,1,,11113137,5281616,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
8,445,3,1,,11113137,5281616,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
9,447,1,1,,11113137,5281616,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
10,448,1,2,,11113137,5281616,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
11,450,1,2,,11113137,5281616,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
12,451,1,2,,11113137,5281616,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
13,526,1,1,,11113137,5281616,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
14,530,1,1,,11113137,5281616,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
15,584,1,3,,11113137,5281616,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
16,585,1,4,,11113137,5281616,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
17,587,1,5,,11113137,5281616,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
18,588,1,4,,11113137,5281616,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
19,589,1,3,,11113137,5281616,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
20,590,1,3,,11113137,5281616,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
21,591,1,4,,11113137,5281616,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
22,592,1,6,,11113137,5281616,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
23,593,1,4,,11113137,5281616,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
24,594,1,4,,11113137,5281616,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
25,595,1,3,,11113137,5281616,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
26,596,1,2,,11113137,5281616,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
27,597,1,3,,11113137,5281616,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
28,603,1,2,,11113137,5281616,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
29,605,1,2,,11113137,5281616,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
30,607,1,3,,11113137,5281616,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
31,662,1,1,,11113137,5281616,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
32,875,1,2,,26754241,5281616,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
33,880,2,1,,26754241,5281616,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
34,880,2,1,,26754241,5281616,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
35,881,2,2,,26754241,5281616,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
36,883,1,3,,11113137,5281616,Active,13699818.0,1559.0,3.1623,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
37,884,1,2,,26754241,5281616,Active,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
38,885,1,2,,26754241,5281616,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
39,886,1,2,,11113137,5281616,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
40,886,1,2,,11113137,5281616,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
41,887,1,2,,26754241,5281616,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
42,889,1,3,,26754241,5281616,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
43,891,1,2,,11113137,5281616,Active,40805836.0,1565.0,19.9526,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
44,892,1,2,,26754241,5281616,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
45,893,1,2,,26754241,5281616,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
46,893,1,2,,26754241,5281616,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
47,894,2,1,,26754241,5281616,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
48,899,1,2,,11113137,5281616,Active,4503219.0,1557.0,3.9811,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
49,900,1,3,,26754241,5281616,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
50,901,1,2,,26754241,5281616,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
51,902,1,2,,26754241,5281616,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
52,912,1,2,,11113137,5281616,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
53,923,1,2,,26754241,5281616,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
54,924,1,2,,26754241,5281616,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
55,926,1,2,,11113137,5281616,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
56,938,1,2,,11113137,5281616,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
57,995,1,2,,26754241,5281616,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
58,1030,2,1,,26754241,5281616,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
59,1379,1,2,,26754241,5281616,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
60,1452,1,1,,26754241,5281616,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
61,1454,1,1,,26754241,5281616,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
62,1457,1,1,,26754241,5281616,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
63,1460,1,3,,26754241,5281616,Inconclusive,92096784.0,4137.0,11.2202,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
64,1463,1,1,,26754241,5281616,Inconclusive,,,17.7828,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
65,1467,1,3,,26754241,5281616,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
66,1468,1,1,,26754241,5281616,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
67,1469,1,1,,26754241,5281616,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
68,1471,2,1,,11113137,5281616,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
69,1471,2,1,,26754241,5281616,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
70,1476,2,1,,26754241,5281616,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
71,1477,1,1,,26754241,5281616,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
72,1478,2,1,,26754241,5281616,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
73,1479,1,2,,26754241,5281616,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
74,1490,2,1,,26754241,5281616,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
75,1519,1,3,,26754241,5281616,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
76,1766,1,1,,26754241,5281616,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
77,1766,1,1,,26754241,5281616,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
78,1768,1,1,,26754241,5281616,Inconclusive,18860839.0,4221.0,11.2202,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
79,1768,1,1,,26754241,5281616,Inconclusive,56550039.0,4297.0,11.2202,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
80,1865,1,1,,26754241,5281616,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
81,1948,1,1,,26754241,5281616,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
82,2016,1,3,,85272545,5281616,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
83,2023,1,3,,85272545,5281616,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
84,2025,1,3,,85272545,5281616,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
85,2029,1,3,,85272545,5281616,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
86,2052,2,1,,85272545,5281616,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
87,2066,1,4,,85272545,5281616,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
88,2101,1,1,,26754241,5281616,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
89,2107,1,1,,26754241,5281616,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
90,2112,1,1,,26754241,5281616,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
91,2147,1,1,,26754241,5281616,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
92,2240,1,1,,85843082,5281616,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
93,2241,1,1,,85843082,5281616,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
94,2275,1,1,,85843082,5281616,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
95,2280,2,3,,85272545,5281616,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
96,2313,1,1,,85843082,5281616,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
97,2316,1,1,,85843082,5281616,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
98,2322,1,1,,85843082,5281616,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
99,2330,1,1,,85843082,5281616,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
100,2380,1,2,,85272545,5281616,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
101,2435,1,2,,85272545,5281616,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
102,2445,1,2,,85272545,5281616,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
103,2451,1,2,,26754241,5281616,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
104,2472,1,2,,26754241,5281616,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
105,2517,2,1,,26754241,5281616,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
106,2517,2,1,,85272545,5281616,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
107,2520,1,4,,85272545,5281616,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
108,2521,1,3,,85272545,5281616,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
109,2524,1,2,,85272545,5281616,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
110,2528,1,2,,26754241,5281616,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
111,2540,1,2,,85272545,5281616,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
112,2544,1,2,,85272545,5281616,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
113,2546,1,1,,26754241,5281616,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
114,2549,1,1,,26754241,5281616,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
115,2551,1,1,,26754241,5281616,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
116,2557,1,3,,85272545,5281616,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
117,2599,1,2,,85272545,5281616,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
118,2606,1,2,,85272545,5281616,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
119,2690,1,2,,85272545,5281616,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
120,2751,2,2,,85272545,5281616,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
121,2796,1,4,,85272545,5281616,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
122,2797,1,2,,85272545,5281616,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
123,2805,2,2,,85272545,5281616,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
124,2806,2,2,,85272545,5281616,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
125,2825,1,2,,85272545,5281616,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
126,30344,6,2,,103274384,5281616,Inconclusive,,,,,Ability to displace [3H]N6-phenylisopropyladenosine binding from adenosine A1 receptor.,Other,9438021.0,
127,32023,9,2,,103274384,5281616,Active,,,0.863,Ki,Binding affinity at Adenosine A1 receptor in rat brain membranes by [3H]PIA displacement.,Confirmatory,8691424.0,
128,32357,9,2,,103274384,5281616,Active,,,0.863,Ki,Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes.,Confirmatory,8576921.0,
129,33152,6,2,,103274384,5281616,Inconclusive,,,,,Ability to displace [3H]-CGS- 21680 binding from adenosine A2A receptor.,Other,9438021.0,
130,33195,8,1,,103274384,5281616,Unspecified,,,,,Ability to displace [125I]-AB-MECA binding from adenosine A3 receptor.,Other,9438021.0,
131,33570,9,1,,103274384,5281616,Active,,,0.966,Ki,Binding affinity at Adenosine A2 receptor in rat striatal membranes by [3H]-CGS- 21680 displacement.,Confirmatory,8691424.0,
132,33936,9,1,,103274384,5281616,Active,,,0.966,Ki,Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement.,Confirmatory,8576921.0,
133,34237,8,5,,103274384,5281616,Active,543740.0,135.0,33.0,Ki,"Binding affinity for HA-tagged mutant human Adenosine A2A receptor (H250N) using [3H]-CGS-21,680 as radioligand expressed in COS-7 cells",Confirmatory,9258366.0,
134,34238,8,5,,103274384,5281616,Active,543740.0,135.0,18.1,Ki,"Binding affinity for HA-tagged mutant human Adenosine A2A receptor (V84L), using [3H]CGS-21680 as radioligand expressed in COS-7 cells",Confirmatory,9258366.0,
135,34239,8,5,,103274384,5281616,Active,543740.0,135.0,16.7,Ki,Binding affinity for HA-tagged wild type human Adenosine A2A receptor (WT) using [3H]CGS-21680 as radioligand expressed in COS-7 cells,Confirmatory,9258366.0,
136,34709,9,2,,103274384,5281616,Active,,,3.15,Ki,Binding affinity against human adenosine A3 receptor in HEK293 cells using [125I]AB-MECA 21680 radioligand.,Confirmatory,8691424.0,
137,34885,9,5,,103274384,5281616,Active,803374855.0,140.0,3.15,Ki,Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells,Confirmatory,8576921.0,
138,69799,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
139,69800,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
140,69801,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
141,69802,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
142,78546,5,5,,103274384,5281616,Inconclusive,,,,,Concentration facilitating 50% of the maximum of the cleavable complex; Not tested,Other,,
143,78696,6,6,,103274384,5281616,Unspecified,,,,,In vitro antibacterial activity was determined as inhibitory concentration causing 50% DNA-gyrase supercoiling inhibition (SCI),Other,,
144,150741,10,5,,103274384,5281616,Active,239938877.0,18671.0,5.9,Kd,Binding affinity to nucleotide-binding domain (NBD2) of P-Glycoprotein,Confirmatory,11140738.0,
145,150742,3,11,,103274384,5281616,Unspecified,239938877.0,18671.0,,,Percent of maximal quenching fluorescence for binding analysis to nucleotide-binding domain (NBD2) of P-Glycoprotein was determined,Other,11140738.0,
146,164264,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
147,164265,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
148,200878,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
149,200879,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
150,205908,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus epidermidis strain OC2603,Other,,
151,206159,6,3,,103274384,5281616,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus aureus strain OC6538,Other,,
152,231110,4,5,,103274384,5281616,Unspecified,,,,,Ratio of binding affinities between rA1 and rA3 of rat striatal membrane.,Other,8691424.0,
153,265760,10,2,,103274384,5281616,Unspecified,75020671.0,,100.0,IC50,Inhibition of FabG,Confirmatory,16722653.0,
154,265761,6,2,,103274384,5281616,Active,,,39.4,IC50,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54,Confirmatory,16722653.0,
155,265762,6,2,,103274384,5281616,Inconclusive,,,,IC50,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1,Confirmatory,16722653.0,
156,265763,3,10,,103274384,5281616,Inactive,74844869.0,,,,Inhibition of FabZ at 100 uM,Other,16722653.0,
157,265764,3,9,,103274384,5281616,Inactive,74844868.0,,,,Inhibition of FabI at 100 uM,Other,16722653.0,
158,293297,7,1,,103274384,5281616,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 min,Other,17166721.0,
159,293298,8,1,,103274384,5281616,Inactive,,,,IC50,Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method,Confirmatory,17166721.0,
160,293299,9,1,,103274384,5281616,Unspecified,,,,,Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production,Other,17166721.0,
161,332645,3,4,,103274384,5281616,Inactive,,,,,Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation up to 100 uM after 30 mins by agarose gel electrophoresis,Other,7769390.0,
162,332646,3,9,,103274384,5281616,Inactive,13959709.0,7153.0,,,Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting up to 100 uM by agarose gel electrophoresis,Other,7769390.0,
163,332929,6,3,,103274384,5281616,Active,,,28.0,EC50,Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay,Confirmatory,8158164.0,
164,332930,6,3,,103274384,5281616,Active,,,44.0,IC50,Cytotoxicity against human H9 cells after 3 days,Confirmatory,8158164.0,
165,332931,3,5,,103274384,5281616,Unspecified,,,,,"Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1 3B",Other,8158164.0,
166,334275,6,3,,103274384,5281616,Active,,,26.8,EC50,Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay,Confirmatory,12027739.0,
167,334276,6,2,,103274384,5281616,Active,,,35.7,EC50,Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay,Confirmatory,12027739.0,
168,334277,6,2,,103274384,5281616,Unspecified,,,93.6,EC50,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,Confirmatory,12027739.0,
169,334278,6,2,,103274384,5281616,Unspecified,,,79.0,EC50,Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,12027739.0,
170,334279,6,3,,103274384,5281616,Active,,,19.2,EC50,Antiproliferative activity against mouse 26-L5 cells after 72 hrs by MTT assay,Confirmatory,12027739.0,
171,334637,3,5,,103274384,5281616,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
172,336123,3,3,,103274384,5281616,Unspecified,,,,,"Antiemetic activity against copper sulfate-induced emesis in young chicks assessed as decrease in retching at 20 mg/kg, ip measured for 10 mins",Other,12350154.0,
173,338023,3,4,,103274384,5281616,Unspecified,,,,,Inhibition of beef heart mitochondrial NADH oxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
174,338024,3,4,,103274384,5281616,Unspecified,,,,,Inhibition of beef heart mitochondrial succinoxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
175,338026,3,4,,103274384,5281616,Unspecified,,,,,Inhibition of rat liver mitochondrial ATPase assessed as specific activity at 0.42 mM relative to control,Other,2959755.0,
176,338027,4,5,,103274384,5281616,Active,,,1.67,I50,Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein,Confirmatory,2959755.0,
177,338750,6,3,,103274384,5281616,Unspecified,,,,,Inhibition of bovine thymus p56LCK-catalyzed phosphorylation of angiotensin 1 by SDS-PAGE,Other,1800636.0,
178,339150,11,1,,103274384,5281616,Unspecified,,,,,Inhibition of bovine thymus p56-LCK protein tyrosine kinase activity,Other,8350096.0,
179,357253,6,2,,103274384,5281616,Unspecified,,,,,Inhibition of Saccharomyces cerevisiae fatty acid synthase,Other,12502337.0,
180,357254,6,2,,103274384,5281616,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028,Other,12502337.0,
181,357255,6,2,,103274384,5281616,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans ATCC 90113,Other,12502337.0,
182,358174,14,1,,103274384,5281616,Unspecified,,,,IC50,Inhibition of p56 lck,Confirmatory,1479375.0,
183,359622,3,5,,103274384,5281616,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 10.8 ug/ml,Other,1338212.0,
184,359623,3,5,,103274384,5281616,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 21.6 ug/ml,Other,1338212.0,
185,359624,3,5,,103274384,5281616,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 5.7 ug/ml,Other,1338212.0,
186,359625,3,5,,103274384,5281616,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 11.4 ug/ml,Other,1338212.0,
187,359646,6,3,,103274384,5281616,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells,Other,1338212.0,
188,379054,6,3,,103274384,5281616,Inactive,,,,IC50,Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA,Confirmatory,10096854.0,
189,379055,4,3,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity,Other,10096854.0,
190,387615,10,5,,103274384,5281616,Unspecified,117293.0,1588.0,100.0,Ki,Inhibition of human aromatase expressed in CHO cells,Confirmatory,18778944.0,
191,399340,9,2,,103274384,5281616,Active,,,1.8,IC50,Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry,Confirmatory,9461655.0,
192,399341,6,2,,103274384,5281616,Active,,,6.74,IC50,Antioxidant activity assessed as superoxide-scavenging activity by nitrite method,Confirmatory,9461655.0,
193,400607,4,3,,103274384,5281616,Unspecified,,,,,Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells,Other,8882428.0,
194,402473,6,2,,103274384,5281616,Active,,,40.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining,Confirmatory,9287415.0,
195,402475,6,2,,103274384,5281616,Unspecified,,,50.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay,Confirmatory,9287415.0,
196,402483,3,4,,103274384,5281616,Active,,,,,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
197,402484,3,4,,103274384,5281616,Active,,,,,Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
198,403635,3,5,,103274384,5281616,Unspecified,,,,,Inhibition of COX2 protein expression in mouse J774A1 cells at 5 uM,Other,16038536.0,
199,404008,5,1,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human KB cells,Other,469554.0,
200,410929,6,2,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human COLO205 cells,Other,19027298.0,
201,410930,6,2,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human A431 cells,Other,19027298.0,
202,410931,6,2,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human MCF7 cells,Other,19027298.0,
203,410932,6,2,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human A549 cells,Other,19027298.0,
204,410933,6,2,,103274384,5281616,Unspecified,,,,,Cytotoxicity against CHO cells,Other,19027298.0,
205,423636,6,2,,103274384,5281616,Unspecified,,,10.0,IC50,Cytotoxicity against human HeLa cells by MTT assay,Confirmatory,19278239.0,
206,429115,9,1,,103274384,5281616,Unspecified,1018618719.0,367.0,,,Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay,Other,19592245.0,
207,429117,9,1,,103274384,5281616,Unspecified,121069.0,2908.0,,,Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay,Other,19592245.0,
208,429118,3,10,,103274384,5281616,Inactive,121069.0,2908.0,,,Antagonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as inhibition of Dex-induced luciferase activity by luciferase reporter gene assay,Other,19592245.0,
209,434955,1,2,,85272545,5281616,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
210,434959,1,1,,85843082,5281616,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
211,434962,1,2,,85272545,5281616,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
212,434973,1,3,,85272545,5281616,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
213,434989,1,1,,85272545,5281616,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
214,435003,1,3,,85272545,5281616,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
215,435022,2,2,,85272545,5281616,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
216,435030,1,2,,85272545,5281616,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
217,435030,1,2,,85272545,5281616,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
218,441659,9,5,,103274384,5281616,Active,116353.0,590.0,6.9,Ki,Inhibition of human plasma BChE by Ellman's method,Confirmatory,19879672.0,
219,441660,9,5,,103274384,5281616,Unspecified,113037.0,43.0,85.6,Ki,Inhibition of human recombinant AChE by Ellman's method,Confirmatory,19879672.0,
220,441661,3,3,,103274384,5281616,Unspecified,,,,,Stability in phosphate buffer at pH 7.4 after 90 mins by spectrophotometry,Other,19879672.0,
221,441664,3,4,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human HepG2 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
222,441665,3,4,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human A549 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
223,449728,1,2,,85272545,5281616,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
224,449762,1,2,,85272545,5281616,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
225,449763,1,3,,85272545,5281616,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
226,450466,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 1 uM after 72 hrs,Other,19615910.0,
227,450467,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 3 uM after 72 hrs,Other,19615910.0,
228,450468,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 10 uM after 72 hrs,Other,19615910.0,
229,450469,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs,Other,19615910.0,
230,450471,5,2,,103274384,5281616,Active,,,17.0,IC50,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs,Confirmatory,19615910.0,
231,450472,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 1 uM after 68 hrs by WST8 assay,Other,19615910.0,
232,450473,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 3 uM after 68 hrs by WST8 assay,Other,19615910.0,
233,450474,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 10 uM after 68 hrs by WST8 assay,Other,19615910.0,
234,450475,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 30 uM after 68 hrs by WST8 assay,Other,19615910.0,
235,450476,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 100 uM after 68 hrs by WST8 assay,Other,19615910.0,
236,450477,5,2,,103274384,5281616,Unspecified,,,100.0,IC50,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability after 68 hrs by WST8 assay,Confirmatory,19615910.0,
237,450478,3,10,,103274384,5281616,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1 uM,Other,19615910.0,
238,450479,3,10,,103274384,5281616,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 3 uM,Other,19615910.0,
239,450480,3,10,,103274384,5281616,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 10 uM,Other,19615910.0,
240,450481,3,10,,103274384,5281616,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 30 uM,Other,19615910.0,
241,450482,3,10,,103274384,5281616,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 uM,Other,19615910.0,
242,450483,8,5,,103274384,5281616,Unspecified,6686057.0,,100.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,19615910.0,
243,450484,3,3,,103274384,5281616,Active,,,,,Inhibition of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells at 1 to 30 uM after 72 hrs,Other,19615910.0,
244,450485,3,3,,103274384,5281616,Active,,,,,Inhibition of TRP1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells at 1 to 30 uM after 72 hrs,Other,19615910.0,
245,450486,3,3,,103274384,5281616,Active,,,,,Inhibition of TRP2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells at 1 to 30 uM after 72 hrs,Other,19615910.0,
246,450487,3,3,,103274384,5281616,Inactive,,,,,Inhibition of microphthalmia-associated transcriptional factor level in theophylline-stimulated mouse B16-4A5 cells at 1 to 30 uM after 24 hrs,Other,19615910.0,
247,450488,3,3,,103274384,5281616,Active,,,,,Inhibition of microphthalmia-associated transcriptional factor level in theophylline-stimulated mouse B16-4A5 cells at 1 to 30 uM after 48 hrs,Other,19615910.0,
248,456183,3,3,,103274384,5281616,Unspecified,,,,,Inhibition of reduced carboxymethylated kappa-casein fibril formation at 50 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay,Other,19931462.0,
249,456187,5,2,,103274384,5281616,Unspecified,,,61.0,IC50,Inhibition of reduced carboxymethylated kappa-casein fibril formation measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
250,456191,4,3,,103274384,5281616,Active,,,,,Inhibition of reduced carboxymethylated kappa-casein fibril formation assessed as formation of shorter and stunted fibrils at 1 uM by transmission electron microscopy,Other,19931462.0,
251,456192,3,3,,103274384,5281616,Unspecified,,,,,Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 40) fibril formation,Other,19931462.0,
252,456193,3,3,,103274384,5281616,Unspecified,,,,,Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 42) fibril formation,Other,19931462.0,
253,456194,5,2,,103274384,5281616,Inactive,,,,IC50,Inhibition of beta amyloid (1 to 40) fibril formation,Confirmatory,19931462.0,
254,456316,3,3,,103274384,5281616,Unspecified,,,,,ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
255,456317,3,3,,103274384,5281616,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent by TEAC assay,Other,19944611.0,
256,456318,3,3,,103274384,5281616,Unspecified,,,,,DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
257,456319,6,1,,103274384,5281616,Unspecified,,,,,ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity,Other,19944611.0,
258,463079,1,2,,85272545,5281616,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
259,463082,1,1,,85272545,5281616,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
260,463104,1,2,,85272545,5281616,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
261,463141,1,2,,85272545,5281616,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
262,463190,1,2,,85272545,5281616,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
263,463195,1,2,,85272545,5281616,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
264,463210,1,2,,85272545,5281616,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
265,463212,1,1,,85272545,5281616,Active,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
266,463218,1,2,,85272545,5281616,Active,285814664.0,855751.0,,,Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
267,463254,1,1,,85272545,5281616,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
268,477928,3,4,,103274384,5281616,Active,,,,,Cytotoxicity against human PANC1 cells in nutrient-deprived condition assessed as preferential cell death after 24 hrs by trypan blue dye exclusion method,Other,20307087.0,
269,485270,1,1,,85272545,5281616,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
270,485272,1,1,,85272545,5281616,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
271,485273,2,1,,85272545,5281616,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
272,485275,1,3,,85272545,5281616,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
273,485290,1,1,,26754241,5281616,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
274,485290,1,1,,85272545,5281616,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
275,485341,1,1,,85272545,5281616,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
276,485346,1,1,,85272545,5281616,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
277,485346,1,1,,85272545,5281616,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
278,485349,1,1,,85272545,5281616,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
279,485353,2,1,,85272545,5281616,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
280,485360,1,1,,85272545,5281616,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
281,485367,1,2,,85272545,5281616,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
282,488837,1,1,,85272545,5281616,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
283,488839,1,1,,85272545,5281616,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
284,488839,1,1,,85272545,5281616,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
285,488847,1,3,,85272545,5281616,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
286,488862,1,1,,85272545,5281616,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
287,488890,1,2,,85272545,5281616,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
288,488895,1,2,,85272545,5281616,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
289,488896,1,1,,85272545,5281616,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
290,488899,1,1,,85272545,5281616,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
291,488965,1,2,,85272545,5281616,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
292,488966,1,1,,85272545,5281616,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
293,489030,2,1,,85272545,5281616,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
294,489031,2,1,,85272545,5281616,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
295,492947,1,1,,85272545,5281616,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
296,492953,1,1,,85272545,5281616,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
297,492956,1,1,,85272545,5281616,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
298,492972,1,1,,85272545,5281616,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
299,493002,1,2,,85272545,5281616,Active,285814664.0,855751.0,8.56,IC50_Mean,Dose Response confirmation of uHTS small molecule inhibitors of tim23-1 yeast via a luminescent assay,Confirmatory,,
300,493005,1,1,,85272545,5281616,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
301,493008,1,1,,85272545,5281616,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
302,493008,1,1,,85272545,5281616,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
303,493008,1,1,,85272545,5281616,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
304,493008,1,1,,85272545,5281616,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
305,493011,1,1,,85272545,5281616,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
306,493012,1,1,,85272545,5281616,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
307,493014,1,1,,85272545,5281616,Inconclusive,,,18.3564,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
308,493036,1,2,,85272545,5281616,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
309,493087,1,1,,85272545,5281616,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
310,493091,1,1,,85272545,5281616,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
311,493098,1,1,,85272545,5281616,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
312,493131,1,1,,85272545,5281616,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
313,493160,1,1,,85272545,5281616,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
314,493187,1,2,,85272545,5281616,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
315,493244,1,1,,85272545,5281616,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
316,493244,1,1,,85272545,5281616,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
317,493244,1,1,,85272545,5281616,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
318,493244,1,1,,85272545,5281616,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
319,502292,2,3,,103274384,5281616,Unspecified,,,,,Antioxidant activity assessed as DDPH radical scavenging activity,Other,20692831.0,
320,502473,2,9,,103274384,5281616,Active,117144.0,1544.0,0.04,IC50,Inhibition of human CYP1A2 by EROD assay,Confirmatory,20696580.0,
321,502474,2,9,,103274384,5281616,Active,117139.0,1543.0,0.077,IC50,Inhibition of human CYP1A1 by EROD assay,Confirmatory,20696580.0,
322,502475,6,5,,103274384,5281616,Active,48429256.0,1545.0,0.025,IC50,Inhibition of human CYP1B1 by EROD assay,Confirmatory,20696580.0,
323,504326,1,2,,85272545,5281616,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
324,504326,1,2,,85272545,5281616,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
325,504327,1,1,,85272545,5281616,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
326,504329,1,1,,85272545,5281616,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
327,504339,1,1,,85272545,5281616,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
328,504357,1,1,,85272545,5281616,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
329,504357,1,1,,85272545,5281616,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
330,504411,1,1,,85272545,5281616,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
331,504414,1,1,,85272545,5281616,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
332,504414,1,1,,85272545,5281616,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
333,504423,1,1,,85272545,5281616,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
334,504441,1,1,,85272545,5281616,Active,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
335,504444,1,1,,85272545,5281616,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
336,504454,1,3,,85272545,5281616,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
337,504462,1,1,,85272545,5281616,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
338,504466,1,1,,85272545,5281616,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
339,504467,1,1,,85272545,5281616,Active,116283940.0,79915.0,12.99,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
340,504490,1,2,,85272545,5281616,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
341,504523,1,1,,85272545,5281616,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
342,504523,1,1,,85272545,5281616,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
343,504558,1,1,,85272545,5281616,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
344,504577,2,2,,85272545,5281616,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
345,504582,2,1,,85272545,5281616,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
346,504621,1,1,,85272545,5281616,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
347,504634,1,1,,85272545,5281616,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
348,504648,1,1,,85272545,5281616,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
349,504657,1,2,,85272545,5281616,Inactive,285809906.0,856395.0,100.0,IC50_Mean,Dose Response confirmation of uHTS small molecule inhibitors of tim23-1: a luminescent  tim10-1 yeast counterscreen.,Confirmatory,,
350,504672,1,2,,85272545,5281616,Active,285809906.0,856395.0,35.5,IC50_Mean,Dose Response confirmation of uHTS small molecule inhibitors of tim23-1: a luminescent  TIM10 yeast counterscreen.,Confirmatory,,
351,504690,1,3,,85272545,5281616,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
352,504692,2,2,,85272545,5281616,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
353,504700,1,1,,85272545,5281616,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
354,504700,1,1,,85272545,5281616,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
355,504706,1,1,,85272545,5281616,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
356,504707,1,1,,85272545,5281616,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
357,504707,1,1,,85272545,5281616,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
358,504720,1,1,,85272545,5281616,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
359,504734,1,1,,85272545,5281616,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
360,504766,2,1,,85272545,5281616,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
361,504775,1,1,,85272545,5281616,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
362,504803,1,1,,85272545,5281616,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
363,504810,1,2,,85272545,5281616,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
364,504812,1,2,,85272545,5281616,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
365,504842,1,1,,85272545,5281616,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
366,504845,1,1,,85272545,5281616,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
367,504847,1,1,,85272545,5281616,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
368,504884,1,2,,85272545,5281616,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
369,504891,1,1,,85272545,5281616,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
370,504894,1,1,,85272545,5281616,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
371,504937,1,2,,85272545,5281616,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
372,540253,1,1,,85272545,5281616,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
373,540253,1,1,,85272545,5281616,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
374,540253,1,1,,85272545,5281616,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
375,540263,1,1,,85272545,5281616,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
376,540263,1,1,,85272545,5281616,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
377,540267,1,1,,85272545,5281616,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
378,540295,1,1,,85272545,5281616,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
379,540303,1,1,,85272545,5281616,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
380,540303,1,1,,85272545,5281616,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
381,540303,1,1,,85272545,5281616,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
382,540308,1,1,,85272545,5281616,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
383,540317,1,1,,85272545,5281616,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
384,540336,1,1,,85272545,5281616,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
385,540336,1,1,,85272545,5281616,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
386,540364,1,2,,85272545,5281616,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
387,588334,1,1,,85272545,5281616,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
388,588335,1,1,,85272545,5281616,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
389,588345,1,1,,85272545,5281616,Inactive,6978787.0,25255.0,,AC50_uM,MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
390,588348,1,1,,85272545,5281616,Inactive,,,,AC50_uM,MLPCN Dyrk1A Artifact Assay Measured in Biochemical System Using Plate Reader - 2124-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
391,588352,1,2,,85272545,5281616,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
392,588354,1,1,,85272545,5281616,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
393,588379,1,2,,124882830,5281616,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
394,588405,1,1,,85272545,5281616,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
395,588413,1,2,,85272545,5281616,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
396,588436,1,1,,85272545,5281616,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
397,588453,1,1,,85272545,5281616,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
398,588456,1,1,,85272545,5281616,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
399,588458,1,1,,85272545,5281616,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
400,588473,1,1,,85272545,5281616,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
401,588473,1,1,,85272545,5281616,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
402,588475,1,2,,85272545,5281616,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
403,588475,1,2,,85272545,5281616,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
404,588478,1,2,,124812137,5281616,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
405,588489,1,1,,85272545,5281616,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
406,588492,1,1,,85272545,5281616,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
407,588493,1,2,,85272545,5281616,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
408,588497,1,2,,85272545,5281616,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
409,588497,1,2,,85272545,5281616,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
410,588497,1,2,,85272545,5281616,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
411,588499,1,3,,85272545,5281616,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
412,588499,1,3,,85272545,5281616,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
413,588499,1,3,,85272545,5281616,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
414,588501,1,2,,85272545,5281616,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
415,588501,1,2,,85272545,5281616,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
416,588501,1,2,,85272545,5281616,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
417,588549,1,1,,85272545,5281616,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
418,588579,1,1,,85272545,5281616,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
419,588579,1,1,,124882830,5281616,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
420,588590,1,1,,85272545,5281616,Inactive,154350220.0,11201.0,89.1251,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
421,588591,1,1,,85272545,5281616,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
422,588621,1,1,,85272545,5281616,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
423,588664,1,2,,85272545,5281616,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
424,588664,1,2,,85272545,5281616,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
425,588674,1,2,,85272545,5281616,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
426,588689,1,1,,85272545,5281616,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
427,588692,2,1,,85272545,5281616,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
428,588726,1,2,,85272545,5281616,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
429,588727,1,1,,85272545,5281616,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
430,588795,1,1,,85272545,5281616,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
431,588814,1,3,,85272545,5281616,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
432,588819,1,4,,85272545,5281616,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
433,588832,1,1,,85272545,5281616,Inactive,7300964.0,,,,Hedgehog Measured in Biochemical System Using Plate Reader - 2070-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
434,588850,1,1,,85272545,5281616,Active,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
435,588852,1,3,,85272545,5281616,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
436,588855,1,1,,85272545,5281616,Inconclusive,18418623.0,4088.0,35.4813,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
437,588856,1,1,,85272545,5281616,Inactive,,,35.4813,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
438,589081,1,10,,103274384,5281616,Unspecified,6136104.0,7367.0,,,Substrate of human UDP-glucuronosyltransferase UGT2B17,Other,,
439,602123,1,1,,85272545,5281616,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
440,602141,1,1,,85272545,5281616,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
441,602162,1,1,,85272545,5281616,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
442,602163,1,1,,85272545,5281616,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
443,602179,1,2,,85272545,5281616,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
444,602229,1,1,,85272545,5281616,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
445,602233,1,1,,85272545,5281616,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
446,602244,1,2,,85272545,5281616,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
447,602247,1,2,,85272545,5281616,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
448,602248,1,2,,85272545,5281616,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
449,602250,1,2,,85272545,5281616,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
450,602252,1,1,,85272545,5281616,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
451,602252,1,1,,85272545,5281616,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
452,602261,1,1,,85272545,5281616,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
453,602274,1,2,,85272545,5281616,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
454,602281,1,1,,85272545,5281616,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
455,602281,1,1,,85272545,5281616,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
456,602310,1,2,,85272545,5281616,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
457,602313,1,1,,85272545,5281616,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
458,602329,1,1,,85272545,5281616,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
459,602332,1,1,,85272545,5281616,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
460,602332,1,1,,124882830,5281616,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
461,602340,1,2,,85272545,5281616,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
462,602342,2,1,,85272545,5281616,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
463,602346,1,1,,85272545,5281616,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
464,602363,1,1,,85272545,5281616,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
465,602393,1,1,,85272545,5281616,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
466,602396,1,2,,85272545,5281616,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
467,602399,1,2,,85272545,5281616,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
468,602405,1,1,,85272545,5281616,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
469,602410,1,1,,85272545,5281616,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
470,602429,1,1,,85272545,5281616,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
471,602438,1,1,,85272545,5281616,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
472,602440,1,1,,85272545,5281616,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
473,602449,1,2,,85272545,5281616,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
474,602472,1,1,,85272545,5281616,Active,90421313.0,1080.0,,,Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
475,602481,1,1,,85272545,5281616,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
476,615921,3,2,,103274384,5281616,Active,,,5.88844,Kd,Binding affinity to ABCB1 nucleotide binding domain 2,Confirmatory,21723648.0,
477,623870,1,1,,85272545,5281616,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
478,623870,1,1,,85272545,5281616,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
479,623877,1,1,,85272545,5281616,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
480,623901,1,1,,85272545,5281616,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
481,624037,1,3,,85272545,5281616,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
482,624038,1,3,,85272545,5281616,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
483,624040,1,3,,85272545,5281616,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
484,624101,1,2,,85843082,5281616,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
485,624125,1,4,,85272545,5281616,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
486,624126,1,3,,85272545,5281616,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
487,624127,1,2,,85272545,5281616,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
488,624136,1,1,,85843082,5281616,Inactive,208342286.0,7157.0,,,mutant P53 Measured in Biochemical System Using Small Molecule MicroArray - 2077-01_Other_SinglePoint_HTS_Activity,Screening,,
489,624138,1,1,,85843082,5281616,Inactive,21618340.0,6774.0,,,SMM STAT-3 Measured in Biochemical System Using Small Molecule MicroArray - 2076-01_Other_SinglePoint_HTS_Activity_Set2,Screening,,
490,624139,1,1,,85843082,5281616,Inactive,34577122.0,4790.0,,,NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity,Screening,,
491,624141,1,1,,85843082,5281616,Inactive,71774083.0,4609.0,,,SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity,Screening,,
492,624151,1,1,,85843082,5281616,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
493,624156,1,1,,85843082,5281616,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
494,624168,1,1,,85272545,5281616,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
495,624169,1,1,,85272545,5281616,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
496,624170,1,1,,85272545,5281616,Inactive,71051501.0,2744.0,12.5893,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
497,624171,1,1,,85272545,5281616,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
498,624172,1,1,,85272545,5281616,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
499,624173,1,3,,85272545,5281616,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
500,624178,1,1,,85272545,5281616,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
501,624202,1,1,,85272545,5281616,Inconclusive,1698399.0,672.0,22.3872,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
502,624204,1,2,,85272545,5281616,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
503,624246,1,1,,85272545,5281616,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
504,624256,1,2,,85272545,5281616,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
505,624260,1,1,,85843082,5281616,Inactive,109633019.0,7468.0,,,NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
506,624263,1,1,,85272545,5281616,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
507,624263,1,1,,85272545,5281616,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
508,624267,1,2,,85272545,5281616,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
509,624267,1,2,,85272545,5281616,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
510,624268,1,3,,85272545,5281616,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
511,624288,1,1,,85272545,5281616,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
512,624291,1,1,,85272545,5281616,Inactive,121312.0,1081.0,,Potency,qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy,Confirmatory,,
513,624296,1,1,,85272545,5281616,Inconclusive,7705682.0,51053.0,32.6427,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
514,624297,1,1,,85272545,5281616,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
515,624304,1,2,,85272545,5281616,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
516,624330,1,2,,85272545,5281616,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
517,624344,1,1,,85272545,5281616,Active,90421313.0,1080.0,3.27,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
518,624344,1,1,1.0,85272545,5281616,Active,90421313.0,1080.0,,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
519,624344,1,1,2.0,85272545,5281616,Unspecified,90421313.0,1080.0,,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
520,624344,1,1,3.0,85272545,5281616,Unspecified,90421313.0,1080.0,,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
521,624344,1,1,4.0,85272545,5281616,Inactive,,,,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
522,624344,1,1,5.0,85272545,5281616,Unspecified,,,,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
523,624344,1,1,6.0,85272545,5281616,Unspecified,,,,IC50_CF-PAF_Mean,Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay,Confirmatory,,
524,624352,1,1,,85272545,5281616,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
525,624354,1,1,,85272545,5281616,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
526,624377,1,1,,85272545,5281616,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
527,624416,1,1,,85272545,5281616,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
528,624417,1,1,,85272545,5281616,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
529,624418,1,1,,85272545,5281616,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
530,624463,1,1,,85272545,5281616,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
531,624464,1,1,,85272545,5281616,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
532,624465,1,1,,85272545,5281616,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
533,624466,1,3,,85272545,5281616,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
534,624467,1,1,,85272545,5281616,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
535,624483,1,1,,85272545,5281616,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
536,624606,1,9,,103274384,5281616,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
537,624607,1,9,,103274384,5281616,Unspecified,549152.0,54659.0,,,Specific activity of expressed human recombinant UGT1A3,Other,10836148.0,
538,624608,3,2,,103274384,5281616,Unspecified,136731.0,54657.0,,,Specific activity of expressed human recombinant UGT1A4,Other,10836148.0,
539,624609,1,9,,103274384,5281616,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
540,624612,1,9,,103274384,5281616,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
541,624616,1,8,,103274384,5281616,Unspecified,332278237.0,7366.0,,,Specific activity of expressed human recombinant UGT2B15,Other,10836148.0,
542,651548,1,1,,85843082,5281616,Inactive,21361095.0,2146.0,,,EZH2/PRC2 methyltransferase inhibitors Measured in Biochemical System Using Plate Reader - 2125-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
543,651550,1,1,,85272545,5281616,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
544,651560,1,1,,85272545,5281616,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
545,651572,1,2,,85272545,5281616,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
546,651602,1,1,,85272545,5281616,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
547,651602,1,1,,85272545,5281616,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
548,651602,1,1,,85272545,5281616,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
549,651635,1,3,,85272545,5281616,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
550,651636,1,1,,85272545,5281616,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
551,651640,1,1,,85272545,5281616,Inconclusive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
552,651644,1,1,,85272545,5281616,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
553,651647,1,1,,85272545,5281616,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
554,651654,1,1,,85272545,5281616,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
555,651658,1,1,,85272545,5281616,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
556,651661,2,1,,85272545,5281616,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
557,651687,1,1,,85272545,5281616,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
558,651699,1,1,,85272545,5281616,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
559,651699,1,1,,85272545,5281616,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
560,651702,1,2,,85272545,5281616,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
561,651704,2,1,,85272545,5281616,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
562,651710,1,1,,85272545,5281616,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
563,651711,2,1,,85272545,5281616,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
564,651718,1,2,,85272545,5281616,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
565,651719,1,2,,85272545,5281616,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
566,651723,1,1,,85272545,5281616,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
567,651724,1,1,,85272545,5281616,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
568,651725,1,1,,85272545,5281616,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
569,651768,1,2,,85272545,5281616,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
570,651800,1,1,,85272545,5281616,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
571,651819,1,1,,85272545,5281616,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
572,651820,1,1,,85272545,5281616,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
573,651821,2,4,,85272545,5281616,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
574,651957,1,1,,85272545,5281616,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
575,651958,1,1,,85272545,5281616,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
576,651965,1,1,,85272545,5281616,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
577,651999,1,1,,85272545,5281616,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
578,652010,1,1,,85272545,5281616,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
579,652017,1,1,,85272545,5281616,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
580,652025,1,1,,85272545,5281616,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
581,652039,1,1,,85272545,5281616,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
582,652048,1,2,,85272545,5281616,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
583,652051,1,1,,85272545,5281616,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
584,652054,1,1,,85272545,5281616,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
585,652067,1,4,,85272545,5281616,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
586,652104,1,1,,85272545,5281616,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
587,652105,1,1,,85272545,5281616,Inconclusive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
588,652106,1,1,,85272545,5281616,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
589,652126,1,3,,85272545,5281616,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
590,652162,2,1,,85272545,5281616,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
591,652163,1,1,,85272545,5281616,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
592,652257,1,1,,85272545,5281616,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
593,654747,1,8,,103274384,5281616,Active,137757.0,1489078.0,,,Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli at 20 nM to 20 uM after 1 hr incubation followed by overnight incubation by Alpha screening technique,Other,22300659.0,
594,658254,1,5,,103274384,5281616,Unspecified,,,,,Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication at 50 uM after 72 hrs by EGFP assay,Other,22445328.0,
595,658255,2,3,,103274384,5281616,Unspecified,,,50.0,CC50,Cytotoxicity against human Huh7.5.1 cells by MTT assay,Confirmatory,22445328.0,
596,671761,1,2,,103274384,5281616,Inactive,,,,,Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
597,671762,1,2,,103274384,5281616,Inactive,,,,,Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
598,671764,1,2,,103274384,5281616,Inactive,,,,,Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA,Other,22578462.0,
599,680300,1,8,,103274384,5281616,Unspecified,238054374.0,5243.0,,,"TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Galangin: 50 uM) in MDR1-expressing NIH-3T3 cells",Other,14985103.0,
600,686940,1,1,,85272545,5281616,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
601,686964,1,1,,85272545,5281616,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
602,686970,1,2,,85272545,5281616,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
603,686971,1,2,,85272545,5281616,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
604,686978,1,1,,85272545,5281616,Inconclusive,79154014.0,55775.0,25.929000000000002,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
605,686978,1,1,,124882830,5281616,Active,79154014.0,55775.0,29.8554,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
606,686979,1,1,,85272545,5281616,Inconclusive,79154014.0,55775.0,14.581,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
607,686979,1,1,,124882830,5281616,Inconclusive,79154014.0,55775.0,18.8375,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
608,686996,1,1,,85272545,5281616,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
609,687014,1,1,,85272545,5281616,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
610,687016,1,1,,85272545,5281616,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
611,690143,1,2,,103274384,5281616,Inactive,,,,,Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control,Other,21824690.0,
612,690144,1,2,,103274384,5281616,Unspecified,,,,,Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control,Other,21824690.0,
613,690145,1,2,,103274384,5281616,Unspecified,,,,,Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay,Other,21824690.0,
614,690148,1,2,,103274384,5281616,Unspecified,,,,,Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay,Other,21824690.0,
615,690149,1,2,,103274384,5281616,Unspecified,,,,,Reducing activity by cyclic voltammetry,Other,21824690.0,
616,696905,1,2,,103274384,5281616,Inactive,,,,,Cytotoxicity against human KB cells at 20 uM after 72 hrs by neutral red staining,Other,23134335.0,
617,697852,1,7,,103274384,5281616,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
618,697853,1,7,,103274384,5281616,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
619,720504,1,1,,85272545,5281616,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
620,720508,1,1,,85272545,5281616,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
621,720509,1,1,,85272545,5281616,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
622,720511,1,1,,85272545,5281616,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
623,720532,1,1,,124882830,5281616,Inactive,420597.0,,10.0,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
624,720533,1,1,,124882830,5281616,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
625,720542,1,2,,85272545,5281616,Inactive,23496270.0,810891.0,12.5893,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
626,720543,1,1,,85272545,5281616,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
627,720551,1,2,,85272545,5281616,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
628,720553,1,2,,85272545,5281616,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
629,720579,2,1,,85272545,5281616,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
630,720580,1,1,,85272545,5281616,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
631,720582,1,1,,85272545,5281616,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
632,720596,1,1,,85272545,5281616,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
633,720647,1,2,,85272545,5281616,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
634,720648,1,1,,85272545,5281616,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
635,720700,1,4,,85272545,5281616,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
636,720702,1,1,,85272545,5281616,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
637,720704,1,4,,85272545,5281616,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
638,720707,1,2,,85272545,5281616,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
639,720708,1,2,,85272545,5281616,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
640,720709,1,2,,85272545,5281616,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
641,720711,1,2,,85272545,5281616,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
642,730328,2,5,,103274384,5281616,Unspecified,156630887.0,2322.0,10.0,IC50,Inhibition of recombinant FLT3 (unknown origin) by TR-FRET assay,Confirmatory,23411073.0,
643,743126,1,1,,85272545,5281616,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
644,743255,1,1,,85272545,5281616,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
645,743266,1,2,,85272545,5281616,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
646,743269,1,1,,85272545,5281616,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
647,743269,1,1,,85272545,5281616,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
648,743279,1,2,,85272545,5281616,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
649,743287,1,1,,85272545,5281616,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
650,743398,1,1,,85272545,5281616,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
651,1053175,2,1,,124812137,5281616,Inactive,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
652,1053197,1,1,,85272545,5281616,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
653,1084380,1,4,,103274384,5281616,Unspecified,75651200.0,,,,Inhibition of Avian myeloblastosis virus reverse transcriptase,Other,,
654,1094164,1,3,,103274384,5281616,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production at 33 uM after 5 min by spectrophotometric analysis,Other,,
655,1097036,1,2,,103274384,5281616,Unspecified,,,,,Antiamoebic activity against Entamoeba histolytica,Other,,
656,1114437,1,2,,103274384,5281616,Inactive,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 at 100 ug/ml measured every 24 hr by BACTEC 460 radiometric assay,Other,,
657,1115338,2,3,,103274384,5281616,Active,113037.0,43.0,0.012,IC50,Inhibition of AChE (unknown origin),Confirmatory,,
658,1127213,1,1,,103274384,5281616,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:10 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
659,1127214,1,1,,103274384,5281616,Unspecified,,,,,Binding affinity to 0.5 mg/ml of DPPC multilamellar vesicles at 100 uM after 2 hrs by centrifugation method,Other,24727463.0,
660,1127215,1,1,,103274384,5281616,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles after 2 hrs by centrifugation method,Other,24727463.0,
661,1127218,1,1,,103274384,5281616,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:20 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
662,1127219,1,1,,103274384,5281616,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:5 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
663,1127220,1,1,,103274384,5281616,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:2 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
664,1127221,1,1,,103274384,5281616,Active,,,,,Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 323 K by nuclear magnetic resonance analysis,Other,24727463.0,
665,1127222,1,1,,103274384,5281616,Active,,,,,Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 303 K by nuclear magnetic resonance analysis,Other,24727463.0,
666,1127223,1,1,,103274384,5281616,Active,,,,,Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 333 K by nuclear magnetic resonance analysis,Other,24727463.0,
667,1127224,1,2,,103274384,5281616,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,24727463.0,
668,1127225,1,1,,103274384,5281616,Unspecified,,,,,Antiproliferative activity against human K562 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control,Other,24727463.0,
669,1127226,1,1,,103274384,5281616,Unspecified,,,,,Antiproliferative activity against human HepG2 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control,Other,24727463.0,
670,1127227,1,1,,103274384,5281616,Unspecified,,,,,Antiproliferative activity against human MCF7 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control,Other,24727463.0,
671,1159524,1,1,,85272545,5281616,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
672,1159606,1,1,,85272545,5281616,Active,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
673,1162612,1,2,,103274384,5281616,Inactive,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
674,1162612,1,2,,103274384,5281616,Inactive,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
675,1162612,1,2,,103274384,5281616,Inactive,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
676,1162613,1,2,,103274384,5281616,Inactive,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
677,1162613,1,2,,103274384,5281616,Inactive,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
678,1162613,1,2,,103274384,5281616,Inactive,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
679,1167300,1,2,,103274384,5281616,Unspecified,,,191.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry,Confirmatory,25278230.0,
680,1224865,1,2,,85272545,5281616,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
681,1254155,1,1,,103274384,5281616,Unspecified,115449.0,759.0,10.0,Ki,Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
682,1254156,1,1,,103274384,5281616,Unspecified,115456.0,760.0,10.0,Ki,Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
683,1254157,1,1,,103274384,5281616,Active,115465.0,762.0,0.5683,Ki,Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
684,1254158,1,1,,103274384,5281616,Active,1168744.0,766.0,0.0245,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
685,1254159,1,1,,103274384,5281616,Active,5915866.0,771.0,0.0418,Ki,Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
686,1256912,1,1,,103274384,5281616,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry,Other,26508549.0,
687,1256913,1,1,,103274384,5281616,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry,Other,26508549.0,
688,1259309,1,1,,124812137,5281616,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
689,1259310,1,1,,333494360,5281616,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
690,1259311,1,1,,124812137,5281616,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
691,1259313,1,1,,85272545,5281616,Active,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
692,1259318,1,1,,85272545,5281616,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
693,1259354,1,1,,348435564,5281616,Inactive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
694,1259389,1,1,,175608052,5281616,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
695,1259407,1,1,,363906421,5281616,Inactive,,,,,CCRIS mutagenicity studies,Other,,
696,1259408,1,1,,363895727,5281616,Active,,,,,GENE-TOX mutagenicity studies,Other,,
697,1259415,1,1,,85272545,5281616,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
698,1259416,1,2,,375171905,5281616,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
699,1259421,1,1,,375171905,5281616,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
